Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

A GlobalData analysis published on March 25, 2026 reports that the US Most Favored Nation (MFN) Policy is already reshaping pharmaceutical markets in Europe. The study shows a significant drop in drug launches and a rise in withdrawals after the